Researchers have developed new AI-driven techniques to rapidly engineer proteins by integrating structural and evolutionary constraints without custom training for specific proteins. Additionally, the University of Copenhagen secured a $109 million grant to establish a European center dedicated to protein design aimed at scientific innovation and practical applications in therapeutics and environmental solutions. These advances signal a growing investment in AI and computational biology for next-generation drug discovery.